Perspectum Diagnostics, a U.K.-based company has received a new grant to develop technology that will improve the diagnosis and monitoring of Type
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of liver disease in the United States. NAFLD is a condition in
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: